TLR3 and breast cancer: Hsp27 in the peripheral blood, through indirect interaction with toll-like receptor 3 (TLR3) and subsequent NF-κB activation, increased the secretion of vascular endothelial growth factor (VEGF) and activated VEGF receptor type 2 in breast cancer cells, ultimately promoting angiogenesis [61,62].